Series C funding round for Dewpoint Therapeutics raising $150M in February 2022
Series C funding round for Dewpoint Therapeutics raising $150M in February 2022
| Investor | Firm Type | Partner |
|---|
Softbank GroupLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Hedge Fund | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private Equity | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Corporate Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Ollen Douglass | |
| Angel | John Hamer | |
| Angel | Gregory Waldorf |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$287M
Top Valuation
-
Dewpoint Therapeutics raised $150M in a Series C round.
The round was announced on 02/01/22.
The round was led by SoftBank.